Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Equity Issued and Repurchased Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Solid Biosciences (SLDB) Non-cash Items (2018 - 2024)

Solid Biosciences (SLDB) has disclosed Non-cash Items for 4 consecutive years, with $1.0 million as the latest value for Q3 2024.

Quarterly Non-cash Items changed N/A to $1.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Sep 2024, changed N/A year-over-year, with the annual reading at $863000.0 for FY2023, 342.33% up from the prior year.
Non-cash Items hit $1.0 million in Q3 2024 for Solid Biosciences, up from $998150.0 in the prior quarter.
In the past five years, Non-cash Items ranged from a high of $1.0 million in Q3 2024 to a low of $863000.0 in Q4 2023.
Historically, Non-cash Items has averaged $950245.5 across 3 years, with a median of $954075.0 in 2020.